Editorial
Published on 05 Apr 2024
Editorial: Targeting immune cell metabolism in tissue fibrosis
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1400858
- 935 views
Type at least 3 characters
1,566 articles
Original Research
Published on 21 Mar 2024
Novel mechanistic study of HDAC6 regulation of rheumatoid arthritis via CMA: exploring potential therapeutic targets
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1383663
- 1,929 views
- 3 citations
Original Research
Published on 21 Mar 2024
PPARδ agonist protects against osteoarthritis by activating AKT/mTOR signaling pathway-mediated autophagy
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1336282
- 1,831 views
- 1 citation
Mini Review
Published on 18 Mar 2024
History and future perspectives of adipose tissue macrophage biology
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1373182
- 2,807 views
- 4 citations
Correction
Published on 13 Mar 2024
Corrigendum: Unveiling the therapeutic potential of exogenous β-hydroxybutyrate for chronic colitis in rats: novel insights on autophagy, apoptosis, and pyroptosis
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1382529
- 1,324 views
Systematic Review
Published on 13 Mar 2024
Different biologics for biological-naïve patients with psoriatic arthritis: a systematic review and network meta-analysis
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1279525
- 4,430 views
- 1 citation
Clinical Trial
Published on 29 Feb 2024
Optimizing aspirin dose for colorectal cancer patients through deep phenotyping using novel biomarkers of drug action
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1362217
- 1,547 views
- 3 citations
Original Research
Published on 29 Feb 2024
Off-label use of Baricitinib improves moderate and severe atopic dermatitis in China through inhibiting MAPK and PI3K/Akt/mTOR pathway via targeting JAK-STAT signaling of CD4+ cells
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1324892
- 4,038 views
- 4 citations
Original Research
Published on 29 Feb 2024
Modification of 4-(4-chlorothiophen-2-yl)thiazol-2-amine derivatives for the treatment of analgesia and inflammation: synthesis and in vitro, in vivo, and in silico studies
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1366695
- 4,007 views
- 4 citations
Review
Published on 23 Feb 2024
Lipotoxicity and immunometabolism in ischemic acute kidney injury: current perspectives and future directions
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1355674
- 2,644 views
- 3 citations
Original Research
Published on 21 Feb 2024
Capsaicin ameliorate pulmonary fibrosis via antioxidant Nrf-2/ PPAR- γ pathway activation and inflammatory TGF-β1/ NF-κB/COX II pathway inhibition
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1333715
- 4,026 views
- 3 citations
Original Research
Published on 15 Feb 2024
Hyaluronic acid-ibuprofen conjugation: a novel ototherapeutic approach protecting inner ear cells from inflammation-mediated damage
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1355283
- 2,377 views
- 3 citations
Review
Published on 15 Feb 2024
Regulation of inflammation during wound healing: the function of mesenchymal stem cells and strategies for therapeutic enhancement
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1345779
- 7,401 views
- 18 citations
Original Research
Published on 13 Feb 2024
Melittin promotes dexamethasone in the treatment of adjuvant rheumatoid arthritis in rats
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1338432
- 2,371 views
- 6 citations
Systematic Review
Published on 07 Feb 2024
Efficacy of hyaluronic acid in the treatment of nasal inflammatory diseases: a systematic review and meta-analysis
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1350063
- 5,254 views
- 4 citations
Perspective
Published on 07 Feb 2024
Pharmacological targeting of the hyper-inflammatory response to SARS-CoV-2-infected K18-hACE2 mice using a cluster of differentiation 36 receptor modulator
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1303342
- 1,621 views
- 2 citations